Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin and Doxycycline in Localized Breast, Uterine, and Cervical Cancer
NCT02874430Phase 2Terminated
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center
- Start
- Jun 2016
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of liquid metformin (Aspargo Labs), doxycycline in breast cancer, uterine cancer, Cervical Cancer (CC), sponsored by Sidney Kimmel Comprehensive Cancer Center. Started Jun 2016; status: terminated.
02
Drugs
liquid metformin (Aspargo Labs)doxycycline
03
Conditions
breast canceruterine cancerCervical Cancer (CC)
Beyond the preview
Go deeper on NCT02874430.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02874430.